Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring blood sugar levels in people with and without prediabetes

Official title: Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)

Run by Abbott Diabetes Care · NCT06921902 · Data updated 2026-11-12

This study is testing how blood sugar levels differ between people with prediabetes and those without to help improve diabetes management in the future.

More Pre Diabetes trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorAbbott Diabetes Care
Industry-sponsored
Locations1 site (Bend, Oregon)
StatusRecruiting
StartedFebruary 28, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 9, 2026
Trial IDNCT06921902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are willing to provide informed consent and do not have a current diabetes diagnosis.

Probably not a fit

Patients with a diagnosis of type 1 diabetes, type 2 diabetes, or those currently on diabetes treatment will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses the FreeStyle Libre 3 Continuous Glucose Monitoring System to evaluate the glycemic profiles of individuals diagnosed with prediabetes compared to those without such a diagnosis. It aims to enroll up to 2000 participants across 20 sites, with approximately half of the subjects having a prediabetes diagnosis. The study is non-randomized and poses a non-significant risk to participants, focusing on understanding glycemic patterns to inform future diabetes management strategies.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into glycemic patterns that may help in the early detection and prevention of diabetes.

How similar studies have gone: Other studies utilizing continuous glucose monitoring have shown promise in understanding glycemic control, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject must be at least 18 years of age.
* Subject must be willing and able to provide written signed and dated informed consent.

Exclusion Criteria:

* Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
* Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
* Subject is known to be pregnant at the time of enrollment.
* Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
* Subject is currently on any form of treatment indicated for the treatment of diabetes.
* Subject is currently on any form of medication indicated for weight loss.

Where it's running

  • Diabetes and Obesity Care
    Bend, Oregon, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.